Breakthrough in rare lung condition treatment: FDA approves Merck’s Sotatercept
In a significant stride forward for patients suffering from a rare and often deadly lung condition, the FDA has given its stamp of approval to Merck’s groundbreaking drug, Sotatercept. This…